Dan Shores at 3rd Annual mRNA-Based Therapeutics Summit

Print PDF Icon
Boston, MA
July 26-28, 2023

Partner Dan Shores will present on "The IP Landscape in the mRNA Space: Winning with Knowledge, Strategy & Innovation" at the 3rd Annual mRNA-Based Therapeutics Summit taking place July 26-28, 2023, in Boston, Massachusetts. Dan's session will be held on Thursday, July 27 during the Clinical Development track. Dan will also participate in a panel session, "Optimizing Targeted Delivery & Cell Specificity," during the Pre-Conference Focus Day on Wednesday, July 26. 

Dan's session on July 27 will provide an overview of the IP landscape in the mRNA space; share key strategies to operate, collaborate, and win; and evaluate innovation approaches and trends. The panel he's participating in on July 26 will aim to answer questions such as what does targeted delivery success look like?; what will make an mRNA therapeutic powerful?; and how can we target the most challenging organs?

The mRNA-Based Therapeutics Summit is returning for its 3rd year this July, showcasing exclusive new data from the movers and shakers in the mRNA industry. 500+ industry pioneers from the likes of the FDA, Pfizer, Moderna, BioNTech, Sanofi and many more are joining the world’s only end-to-end meeting focused on the next generation of mRNA-based therapeutics and vaccines.

To learn more about the event, and to register, please visit the event website.

Jump to Page

By using this site, you agree to our updated Privacy Policy and our Terms of Use.